Essential role of nuclear factor κB in the induction of eosinophilia in allergic airway inflammation

Journal of Experimental Medicine

Volumn 188, Issue 9, 1998, Pages 1739-1750

  Yang, Liyan ^a   Cohn, Lauren ^a   Zhang, Dong Hong ^a   Homer, Robert ^a   Ray, Anuradha ^a   Ray, Prabir ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allergic inflammation; Eosinophils; Eotaxin; Interleukin 5; Nuclear factor B

Indexed keywords

CYTOKINE; EOTAXIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ALLERGIC ASTHMA; ALLERGY; ANIMAL CELL; ANIMAL MODEL; ARTICLE; ASTHMA; CELL ADHESION; CONTROLLED STUDY; EOSINOPHILIA; INFLAMMATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIGENS; ASTHMA; BASE SEQUENCE; CHEMOKINES, CC; CYTOKINES; DNA PRIMERS; EOSINOPHILIA; GENE EXPRESSION; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-4; INTERLEUKIN-5; LUNG; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; NF-KAPPA B P50 SUBUNIT; OVALBUMIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TH2 CELLS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0032476742     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.9.1739     Document Type: Article

References (90)

1. Hamid, Q., M. Azzawi, S. Ying, R. Moqbel, A.J. Wardlaw, C.J. Corrigan, B. Bradley, S.R. Durham, J.V. Collins, P.K. Jeffery, et al. 1991. Expression of mRNA for interleukin 5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87:1541-1546.
2. Walker, C., M.K. Kaegi, P. Braun, and K. Blaser. 1991. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J. Allergy Clin. Immunol. 88:935-942.
3. H2-like bronchoalveolar T-lymphocyte population in atopic asthma. N. Engl. J. Med. 326:298-304.
4. de Monchy, J.G.R., H.F. Kaufmann, P. Venge, G.H. Koeter, H.M. Jansen, H.J. Sluiter, and K. de Vries. 1985. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 131:373-376.
5. Gleich, G.J., N.A. Flavahan, T. Fujisawa, and P.M. Vanhoutte. 1988. The eosinophil as a mediator of damage to respiratory epithelium: a model for bronchial hyperreactivity. J. Allergy Clin. Immunol. 81:776-781.
6. Frick, W.E., J.B. Sedgwick, and W.W. Busse. 1989. The appearance of hypodense eosinophils in antigen-dependent late phase asthma. Am. Rev. Respir. Dis. 139:1401-1406.
7. Bousquet, J., P. Chanez, J.Y. Lacoste, G. Barneon, N. Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-Lafontaine, P. Godard, and F.B. Michel. 1990. Eosinophilic inflammation in asthma. N. Engl. J. Med. 323:1033-1039.
8. Azzawi, M., B. Bradley, P.K. Jeffrey, A.J. Frew, A.J. Wardlaw, G. Knowles, B. Asoufi, J.V. Collins, S. Durham, and A.B. Kay. 1990. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable asthmatics. Am. Rev. Respir. Dis. 142:1407-1413.
9. Djukanovic, R., J.W. Wilson, K.M. Britten, S.J. Wilson, A.F. Walls, W.R. Roche, P.H. Howarth, and S.T. Holgate. 1990. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am. Rev. Respir. Dis. 142:863-871.
10. Broide, D.H., G.J. Gleich, A.J. Cuomo, D.A. Coburn, E.C. Federman, L.B. Schwartz, and S.I. Wasserman. 1991. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J. Allergy Clin. Immunol. 88:637-648.
11. Dahl, R., P. Venge, and I. Olsson. 1978. Variations of blood eosinophils and eosinophil cationic protein in serum in patients with bronchial asthma. Allergy. 33:211-215.
12. Corrigan, C.J., A. Hartnell, and A.B. Kay. 1988. T lymphocyte activation in acute severe asthma. Lancet. 1:1129-1132.
13. Walker, C., J. Virchow, P.L.B. Bruijnzeel, and K. Blaser. 1991. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J. Immunol. 146:1829-1835.
14. Ying, S., S.R. Durham, J. Barkans, K. Masuyama, M. Jacobson, S. Rak, O. Lowhagen, R. Moqbel, A.B. Kay, and Q.A. Hamid. 1993. T cells are the principal source of interleukin-5 mRNA in allergen-induced rhinitis. Am. J. Respir. Cell Mol. Biol. 9:356-360.
15. Maggi, E., and S. Romagnani. 1994. Role of T cells and T-cell-derived cytokines in the pathogenesis of allergic diseases. Ann. NY Acad. Sci. 725:2-12.
16. + T cells in the pathogenesis of allergic diseases. Proc. Soc. Exp. Biol. Med. 215:11-20.
17. Coffman, R.L., B.W.P. Seymour, S. Hudak, J. Jackson, and D. Rennick. 1989. Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science. 245:308-310.
18. Foster, P.S., S.P. Hogan, A.J. Ramsay, K.I. Matthaei, and I.G. Young. 1996. Interleukin-5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in mouse asthma model. J. Exp. Med. 183:195-201.
19. Kopf, M., F. Brombacher, P.D. Hodgkin, A.J. Ramsay, E.A. Milbourne, W.J. Dai, K.S. Ovington, C.A. Behm, G. Kohler, I.G. Young, et al. 1996. IL-5 deficient mice have a development defect in CD5+ B-1 cells and lack eosinophils but have normal antibody and cytotoxic T cell responses. Immunity. 4:15-24.
20. Yamaguchi, Y., T. Suda, J. Suda, M. Eguchi, Y. Miura, N. Harada, S. Kitamura, A. Tominaga, and K. Takatsu. 1988. Purified interleukin-5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167:43-56.
21. Lopez, A.F., C.J. Sanderson, J.R. Gamble, H.D. Campbell, I.G. Young, and M.A. Vadas. 1988. Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med. 167:219-224.
22. Clutterbuck, E.J., E.M. Hirst, and C.J. Sanderson. 1989. Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparisons and interactions with IL-1, IL-3, IL-6 and GM-CSF. Blood. 73:1504-1512.
23. Collins, P.D., S. Marleau, D.A. Griffiths-Johnson, P.J. Jose, and T.J. Williams. 1995. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med. 182:1169-1174.
24. Baldwin, A.S., Jr. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
25. Baeuerle, P.A., and D. Baltimore. 1996. NF-κB: ten years after. Cell. 87:13-20.
26. Siebenlist, U., G. Franzoso, and K. Brown. 1994. Structure, regulation and function of NF-κB. Annu. Rev. Cell. Biol. 10: 405-455.
27. Blackwell, T.S., and J.W. Christman. 1997. The role of nuclear factor-kappa B in cytokine gene regulation. Am. J. Respir. Cell. Mol. Biol. 17:3-9.
28. Barnes, P.J. 1997. Nuclear factor-kappa B. Int. J. Biochem. Cell. Biol. 29:867-870.
29. Sha, W.C. 1998. Regulation of immune responses by NF-κB/Rel transcription factors. J. Exp. Med. 187:143-146.
30. Schmitz, M.L., and P.A. Baeuerle. 1991. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO (Eur. Mol. Biol. Organ.) J. 10:3805-3817.
31. Kang, S.-M., A.-C. Tran, M. Grilli, and M.J. Lenardo. 1992. NF-κB subunit regulation in nontransformed CD4+ T lymphocytes. Science. 256:1451-1456.
32. Franzoso, G., V. Bours, S. Park, M. Tomita-Yamaguchi, K. Kelly, and U. Siebenlist. 1992. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kB-mediated inhibition. Nature. 359:339-342.
33. Ray, P., L. Yang, D.-H. Zhang, K. Ghosh, and A. Ray. 1997. Selective upregulation of cytokine-induced RANTES gene expression in lung epithelial cells by overexpression of IκBR. J. Biol. Chem. 272:20191-20197.
34. Ishikawa, H., E. Claudio, D. Dambach, C. Raventos-Suarez, C. Ryan, and R. Bravo. 1998. Chronic inflammation and susceptibility to bacterial infection in mice lacking the polypeptide p 105 precursor (NF-κB1) but expressing p50. J. Exp. Med. 187:985-996.
35. Beg, A.A., W.C. Sha, R.T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature. 376:167-170.
36. Sha, W.C., H.-C. Liou, E.I. Tuomanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell. 80:321-330.
37. Snapper, C.M., P. Zelazowski, F.R. Rosas, M.R. Kehry, M. Tian, D. Baltimore, and W.C. Sha. 1996. B cells from p50/ NF-kB knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription and Ig class switching. J. Immunol. 156:183-191.
38. + T-lymphocytes and interleukin-5 mediate antigen-induced eosinophil infiltration into the mouse trachea. Am. Rev. Respir. Dis. 146:374-377.
39. + T lymphocytes prevents antigen-induced airway hyperreactivity and pulmonary eosinophilia. Am. J. Respir. Cell. Mol. Biol. 10:587-593.
40. Corry, D.B., H.G. Folfesson, M.L. Warnock, D.J. Erie, M.A. Matthay, J.P. Wiener-Kronish, and R.M. Locksley. 1996. Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity. J. Exp. Med. 183:109-117.
41. Cohn, L., R.J. Homer, A. Marinov, J. Rankin, and K. Bottomly. 1997. Induction of airway mucus production by T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J. Exp. Med. 186:1737-1747.
42. Kung, T.T., H. Jones, G.K. Adams III, S.P. Umland, W. Kreutner, R.W. Egan, R.W. Chapman, and A.S. Watnick. 1994. Characterization of a murine model of allergic pulmonary inflammation. Int. Arch. Allergy Immunol. 105:83-90.
43. Ray, P., W.L. Tang, P. Wang, R. Homer, C. Kuhn III, R.A. Flavell, and J.A. Elias. 1997. Regulated overexpression of interleukin 11 in the lung: use to dissociate development-dependent and -independent effects. J. Clin. Invest. 100:2501-2511.
44. Wong, S., S. Guerder, I. Visintin, E. Reich, K.E. Swenson, R.A. Flavell, and C.A. Janeway, Jr. 1995. Expression of the co-stimulator molecule B7-1 in pancreatic B cells accelerates diabetes in the NOD mouse. Diabetes. 44:326-329.
45. Gonzalo, J.A., C.M. Lloyd, L. Kremer, E. Finger, A.C. Martinez, M.H. Siegelman, M. Cybulsky, and J.C. Gutierrez-Ramos. 1996. Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors. J. Clin. Invest. 98:2332-2345.
46. Siegel, M.D., D.-H. Zhang, P. Ray, and A. Ray. 1995. Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements. J. Biol. Chem. 270:24548-24555.
47. Zhang, D.-H., L. Cohn, P. Ray, K. Bottomly, and A. Ray. 1997. Transcription factor GATA-3 is differentially expressed in Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene. J. Biol. Chem. 272:21597-21603.
48. Zhang, D.-H., L. Yang, and A. Ray. 1998. Differential responsiveness of the interleukin-5 (IL-5) and IL-4 genes to transcription factor GATA-3. J. Immunol. 161:3817-3821.
49. Liou, H.-C., G.P. Nolan, S. Ghosh, T. Fujita, and D. Baltimore. 1992. The NF-κB precursor, p105, contains an internal IκB-like inhibitor that preferentially inhibits p50. EMBO (Eur. Mol. Biol. Organ.) J. 11:3003-3009.
50. Inoue, J.-I., L.D. Kerr, A. Kakizuka, and I.M. Verma. 1992. IκBγ, a 70kd protein identical to the C-terminal half of p110 NF-κB: a new member of the IκB family. Cell. 68:1109-1120.
51. Iademarco, M.F., J.J. McQuillan, G.D. Rosen, and D.C. Dean. 1992. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 267: 16323-16329.
52. Neish, A.S., A.J. Williams, H.J. Palmer, M.Z. Whitley, and T. Collins. 1992. Functional analysis of the human vascular cell adhesion molecule 1 promoter. J. Exp. Med. 176:1583-1593.
53. Chen, C.C., C.L. Rosenbloom, D.C. Anderson, and A.M. Manning. 1995. Selective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. J. Immunol. 155:3538-3545.
54. Read, M.A., A.S. Neish, F.W. Luscinskas, V.J. Palombella, T. Maniatis, and T. Collins. 1995. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression. Immunity. 2:493-506.
55. Roebuck, K.A., A. Rahman, V. Lakshminarayanan, K. Janakidevi, and A.B. Malik. 1995. H2O2 and tumor necrosis factor-alpha activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distinct cis-regulatory elements within the ICAM-1 promoter. J. Biol. Chem. 270:18966-18974.
56. Shu H.B., A.B. Agranoff, E.G. Nabel, K. Leung, C.S. Duckett, A.S. Neish, T. Collins, and G.J. Nabel. 1993. Differential regulation of vascular cell adhesion molecule 1 gene expression by specific NF-κB subunits in endothelial and epithelial cells. Mol. Cell. Biol. 13:6283-6289.
57. Ahmad, M., N. Marui, R.W. Alexander, and R.M. Medford. 1995. Cell type-specific transactivation of the VCAM-1 promoter through an NF-κB enhancer motif. J. Biol. Chem. 270: 8976-8983.
58. Ledebur, H.C., and T.P. Parks. 1995. Transcriptional regulation of the intercellular adhesion molecule-1 gene by inflammatory cytokines in human endothelial cells. Essential roles of a variant NF-κB site and p65 homodimers. J. Biol. Chem. 270:933-943.
59. McCarty, J.M., E.K. Yee, T.A. Deisher, J.M. Harlan, and K. Kaushansky. 1995. Interleukin-4 induces endothelial vascular cell adhesion molecule-1 (VCAM-1) by an NF-κB-independent mechanism. FEBS Lett. 372:194-198.
60. + T cells in response to MIP-1α and MIP-1β. Science. 260:355-358.
61. Vanguri, P., and J.M. Farber. 1990. Identification of CRG-2: an interferon-inducible mRNA predicted to encode a murine monokine. J. Biol. Chem. 265:15049-15057.
62. MacLean, J.A., R. Ownbey, and A.D. Luster. 1996. T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophilia. J. Exp. Med. 184:1461-1469.
63. Sallusto, F., D. Lenig, C.R. Mackay, and A. Lanzavecchia. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875-883.
64. Sallusto, F., C.R. Mackay, and A. Lanzavecchia. 1998. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 277:2005-2007.
65. Gerber, B.O., M.P. Zanni, M. Uguccioni, M. Loetscher, C.R. Mackay, W.J. Pichler, N. Yawalkar, M. Baggiolini, and B. Moser. 1997. Functional expression of the eotaxin receptor CCR3 in T lymphocytes co-localizing with eosinophils. Curr. Biol. 7:836-843.
66. Bonecchi, R., G. Bianchi, P.P. Bordignon, D. D'Ambrosio, R. Lang, A. Borsatti, S. Sozzani, P. Allavena, P.A. Gray, A. Mantovani, and F. Sinigaglia. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129-134.
67. Daugherty, B.L., S.J. Siciliano, J. DeMartino, L. Malkowitz, A. Sirontino, and M.S. Springer. 1996. Cloning, expression and characterization of the human eotaxin receptor. J. Exp. Med. 183:2349-2354.
68. Ponath, P.D., S. Qin, T.W. Post, J. Wang, L. Wu, N.P. Gerard, W. Newman, C. Gerard, and C.R. Mackay. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. J. Exp. Med. 183:2437-2448.
69. Gao, J.-L., A. Sen, L. Tiffany, O. Yoshi, M. Rothenberg, P. Murphy, and A. Luster. 1996. Identification of a mouse eosinophil-selective receptor for the CC chemokine eotaxin. Biochem. Biophys. Res. Commun. 223:679-684.
70. Sallusto, F., C.R. Mackay, and A. Lanzavecchia. 1997. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 277:2005-2007.
71. Jose, P.J., I.M. Adcock, D.A. Griffiths-Johnson, N. Berkman, T.N.C. Wells, T.J. Williams, and C.A. Power. 1994. Eotaxin: cloning of an eosinophil chemoattractant cytokine and increased mRNA expression in allergen-challenged guinea-pig lungs. Biochem. Biophys. Res. Commun. 205:788-794.
72. Rothenberg, M.E., A.D. Luster, and P. Leder. 1995. Murine eotaxin: an eosinophil chemoattractant inducible in endothelial cells and in interleukin 4-induced tumor suppression. Proc. Natl. Acad. Sci. USA. 92:8960-8964.
73. Ponath, P.D., S. Qin, D.J. Ringler, I. Clark-Lewis, J. Wang, N. Kassam, H. Smith, X. Shi, J.A. Gonzalo, W. Newman, et al. 1996. Cloning of the human eosinophil chemoattractant eotaxin. Expression, receptor binding, and functional properties suggest a mechanism for the selective recruitment of eosinophils. J. Clin. Invest. 97:604-612.
74. Garcia-Zepeda, E.A., M.E. Rothenberg, R.T. Ownbey, J. Celestin, P. Leder, and A.D. Luster. 1996. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat. Med. 2:449-456.
75. Gonzalo, J.A., G.Q. Jia, V. Aguirre, D. Friend, A.J. Coyle, N.A. Jenkins, G.S. Lin, H. Katz, A. Lichtman, N. Copeland, et al. 1996. Mouse eotaxin expression parallels eosinophil accumulation during lung allergic inflammation but it is not restricted to a Th2-type response. Immunity. 4:1-14.
76. Rothenberg, M.E., R. Ownbey, P.D. Mehlhop, P.M. Loiselle, M. van de Rijn, J.V. Bonventre, H.C. Oettgen, P. Leder, and A.D. Luster. 1996. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice. Mol. Med. 2:334-348.
77. Sanz, M.-J., P.D. Ponath, C.R. Mackay, W. Newman, M. Miyasaka, T. Tamatani, B.F. Flanagan, R.R. Lobb, T.J. Williams, S. Nourshargh, and T.J. Williams. 1998. Human eotaxin induces α4 and β2 integrin-dependent eosinophil accumulation in rat skin in vivo: delayed generation of eotaxin in response to IL-4. J. Immunol. 160:3569-3576.
78. Garcia-Zepeda, E.A., M.E. Rothenberg, S. Weremowicz, M.N. Sarafi, C.C. Morton, and A.D. Luster. 1997. Genomic organization, complete sequence, and chromosomal location of the gene for human eotaxin (SCYA11), an eosinophil-specific CC chemokine. Genomics. 41:471-476.
79. Humbles, A.A., D.M. Conroy, S. Marleau, S.M. Rankin, R.T. Palframan, A.E. Proudfoot, T.N. Wells, D. Li, P.K. Jeffery, D.A. Griffiths-Johnson, et al. 1997. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J. Exp. Med. 186:601-612.
80. Mould, A.W., K.I. Matthaei, I.G. Young, and P.S. Foster. 1997. Relationship between interleukin 5 and eotaxin in regulating blood and tissue eosinophilia in mice. J. Clin. Invest. 99:1064-1071.
81. Swain, S.L. 1994. Generation and in vivo persistence of polarized Th1 and Th2 cells. Immunity. 1:553-552.
82. Sewell, W.A., and H.H. Mu. 1996. Dissociation of production of interleukin-4 and interleukin-5. Immunol. Cell. Biol. 74:274-277.
83. Doi, S., V. Gemou-Engesaeth, A.B. Kay, and C.J. Corrigan. 1994. Polymerase chain reaction quantification of cytokine messenger RNA expression in peripheral blood mononuclear cells of patients with acute exacerbations of asthma: effect of glucocorticoid therapy. Clin. Exp. Allergy. 24:854-867.
84. Tendler, C.L., J.D. Burton, J. Jaffe, D. Danielpour, M. Charley, J.P. McCoy, M.R. Pittelkow, and T.A. Waldmann. 1994. Abnormal cytokine expression in Sezary and adult T-cell leukemia cells correlates with the functional diversity between these T-cell malignancies. Cancer Res. 54:4430-4435.
85. Jung, T., U. Schauer, C. Rieger, K. Wagner, K. Einsle, C. Neumann, and C. Heusser. 1995. Interleukin-4 and interleukin-5 are rarely co-expressed by human T cells. Eur. J. Immunol. 25:2413-2416.
86. Zheng, W.-p., and R.A. Flavell. 1997. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 89:587-596.
87. Lee, H.J., A. O'Garra, K.-I. Arai, and N. Arai. 1998. Characterization of cis-regulatory elements and nuclear factors conferring Th2-specific expression of the IL-5 gene: a role for a GATA-binding protein. J. Immunol. 160:2343-2352.
88. Ho, I.-C., M.R. Hodge, J.W. Rooney, and L.H. Glimcher. 1996. The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell. 85:973-983.
89. Rao, A., C. Luo, and P.G. Hogan. 1997. Transcription factors of the NF-AT family: regulation and function. Annu. Rev. Immunol. 15:707-747.
90. Ray, P., D.-H. Zhang, J.A. Elias, and A. Ray. 1995. Cloning of a differentially expressed IκB-related protein. J. Biol. Chem. 270:10680-10685.